Transcranial Electrical Stimulation for Treating Chronic Pain in Inflammatory Demyelinating Diseases
Recruiting now · Not applicable
Conditions studied: Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
In brief
Non-invasive neurostimulation can effectively improve patients' symptoms and has shown good therapeutic efficacy in alleviating the symptoms of IIDDs (Inflammatory Immune-mediated Demyelinating Diseases). However, some patients have not achieved the desired results, which may be due to individual differences in neural responsiveness . Therefore, this study aims to assess the therapeutic effect of transcranial electrical stimulation on improving symptoms such as painful spasm in IIDDs patients, by considering both the overall characteristics of IIDDs disease symptoms and individual differences in patients. The study will explore the imaging characteristics, electrophysiological features of the disease symptoms, and their relationship with clinical manifestations, while analyzing the key factors that influence treatment efficacy.
Key facts
- Study ID
- NCT06942611
- Run by
- Xuanwu Hospital, Beijing
- People needed
- 80
- Starts
- 2025-05-03
- Expected to finish
- 2027-07-31
- Last updated by the study team
- 2025-07-01
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients diagnosed with neuromyelitis optica spectrum disorder, multiple sclerosis, or other central nervous system inflammatory demyelinating diseases that meet the diagnostic criteria;
- Numeric Rating Scale (NRS) pain score ≥4;
- Age between 18 and 65 years, regardless of gender;
- Stable dose of immunosuppressive therapy for at least one month;
- EDSS score ≤6;
- Right-handed;
- Agree to participate and sign the informed consent form.
You may not qualify if…
- A history of relapse within the past month;
- Recent medication adjustments or treatment with modified electroconvulsive therapy, transcranial magnetic stimulation, or other neurostimulation techniques within the past month;
- Participation in any other clinical trial within the past month or currently participating in another clinical trial;
- Presence of cochlear implants, pacemakers, or implanted stimulators in the brain;
- Skin integrity at the electrode placement site is compromised, or allergy to electrode gel or adhesive;
- A history of epilepsy, hydrocephalus, central nervous system tumors, brain injury, or intracranial infections;
- Pregnant or breastfeeding women, or those planning to become pregnant in the near future;
- A score of ≥3 on item 3 (suicide item) of the HDRS-17, or a history of severe psychiatric disorders;
- Presence of severe or unstable organic diseases;
- Poor patient compliance preventing cooperation with treatment, follow-up, or clinical, EEG, and imaging data collection;
- Any other situation deemed unsuitable for participation in the study by the investigator.
Where it is running
- Xuanwu Hospital, Capital Medical University — Beijing, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.